Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management will participate at both the Bryan, Garnier & Co 6th European Healthcare Conference and the Piper Jaffray 30th Annual Healthcare Conference.

The Bryan, Garnier & Co 6th European Healthcare Conference will take place in Paris, France, on November 22-23, 2018.  The Company will participate in investor meetings at the Conference.

The Piper Jaffray 30th Annual Healthcare Conference will take place in New York, NY on November 27-29, 2018 and the Company is scheduled to participate in a fireside chat on Tuesday, November 27 at 11:30 am Eastern Time.  A live webcast of the discussion can be accessed here.  An archived webcast recording will also be available under Events & Webcasts in the Investors section of the Company’s website.

Download press release(s)

Press release

144.14 Ko

Communiqué de presse

148.38 Ko

Celyad Announces Third Quarter 2018 Business Update

Next News

Celyad Announces Third Quarter 2018 Business Update